Clinical Trial Update: Valacyclovir Augmentation for Cognitive and Functional Remediation in Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating valacyclovir augmentation for cognitive and functional remediation in schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Simplex Virus Infection
• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Valacyclovir (Valacyclovir)

Snippet

Sponsor: University of Pittsburgh | Conditions: Herpes Simplex, Schizophrenia | Phase 4 | Status: COMPLETED